| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Double-Edged Sword—Cardiovascular Concerns of Potential Anti-COVID-19 Drugs
|
Yu, Wen-Liang
|
|
|
35 |
2 |
p. 205-214
|
artikel
|
| 2 |
Antiplatelet Therapy in Elderly Patients with Acute Coronary Syndromes: the Clopidogrel Revenge: Possible Reasons for a Bright Comeback
|
De Servi, Stefano
|
|
|
35 |
2 |
p. 399-401
|
artikel
|
| 3 |
Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
|
Talasaz, Azita Hajhossein
|
|
|
35 |
2 |
p. 249-259
|
artikel
|
| 4 |
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation
|
Briasoulis, Alexandros
|
|
|
35 |
2 |
p. 261-272
|
artikel
|
| 5 |
Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction
|
Yurista, Salva R.
|
|
|
35 |
2 |
p. 403
|
artikel
|
| 6 |
Correction to: The Effect of Enhanced External Counterpulsation on Platelet Aggregation in Patients with Coronary Heart Disease
|
Wang, Yating
|
|
|
35 |
2 |
p. 405
|
artikel
|
| 7 |
Dietary Cholesterol Exacerbates Statin-Induced Hepatic Toxicity in Syrian Golden Hamsters and in Patients in an Observational Cohort Study
|
Yu, Qiongyang
|
|
|
35 |
2 |
p. 367-380
|
artikel
|
| 8 |
Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4–5 Chronic Kidney Disease or on Dialysis
|
Chen, Chen
|
|
|
35 |
2 |
p. 273-281
|
artikel
|
| 9 |
Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial
|
Mao, Shuai
|
|
|
35 |
2 |
p. 321-329
|
artikel
|
| 10 |
Impact of PRECISE-DAPT and DAPT Scores on Dual Antiplatelet Therapy Duration After 2nd Generation Drug-Eluting Stent Implantation
|
Jang, Ji-Yong
|
|
|
35 |
2 |
p. 343-352
|
artikel
|
| 11 |
Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes
|
Euler, Gerhild
|
|
|
35 |
2 |
p. 353-365
|
artikel
|
| 12 |
Maxacalcitol (22-Oxacalcitriol (OCT)) Retards Progression of Left Ventricular Hypertrophy with Renal Dysfunction Through Inhibition of Calcineurin-NFAT Activity
|
Inoue, Kazunori
|
|
|
35 |
2 |
p. 381-397
|
artikel
|
| 13 |
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration
|
Chandrasekhar, Jaya
|
|
|
35 |
2 |
p. 309-320
|
artikel
|
| 14 |
Overlapping Drug-Eluting Stent Is Associated with Increased Definite Stent Thrombosis and Revascularization: Results from 15,561 Patients in the AUTHENTIC Study
|
Chen, Xiang
|
|
|
35 |
2 |
p. 331-341
|
artikel
|
| 15 |
Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis
|
Tsiachris, Dimitris
|
|
|
35 |
2 |
p. 293-308
|
artikel
|
| 16 |
Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm
|
Peng, Xiang
|
|
|
35 |
2 |
p. 231-247
|
artikel
|
| 17 |
Report of the British Society for Cardiovascular Research Inaugural Online Autumn Meeting 2020
|
Arthur, Helen M.
|
|
|
35 |
2 |
p. 407-409
|
artikel
|
| 18 |
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
|
Aliter, Kholoud F.
|
|
|
35 |
2 |
p. 195-203
|
artikel
|
| 19 |
Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment
|
Gąsecka, Aleksandra
|
|
|
35 |
2 |
p. 215-229
|
artikel
|
| 20 |
Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study
|
Lévy, Samuel
|
|
|
35 |
2 |
p. 283-292
|
artikel
|
Tijdschrift beschrijving